|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Issuance of common stock for services | |||||
| Amortization of operating lease right-of-use asset | |||||
| Depreciation | |||||
| Deferred income tax expense | |||||
| Changes in operating assets and liabilities: | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued compensation | |||||
| Operating lease liability | |||||
| Net Cash Used In Operating Activities | |||||
| Cash Flows From Investing Activities: | |||||
| License payment | |||||
| Net Cash Used In Investing Activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from common stock option exercises | |||||
| Repayment of advance from employee | |||||
| Merger, net | |||||
| Net proceeds from registered direct offerings | |||||
| Net proceeds from common stock offerings | |||||
| Net Cash Provided By Financing Activities | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents – Beginning of Year | |||||
| Cash and Cash Equivalents – End of Year | |||||
| IPR&D Milestones included in License Payable | |||||
| Prepaid Manufacturing transferred to Inventory | |||||
| Supplemental Disclosures of Cash Flow Information and Non-cash Activities: | |||||
| IPR&D Milestones included in License Payable | |||||
| Net Prepaid Manufacturing transferred to Inventory | |||||
| Operating lease right-of-use asset and liability recorded | |||||
| Interest paid | |||||
Loading...